The blood-testis barrier as a target of some chemotherapeutic agents

Chemotherapy

Volumn 53, Issue 6, 2007, Pages 446-448

  Pereira, M L ^a   Garcia E Costa, F ^b  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

Author keywords

Blood testis barrier; Budotitane; Chemotherapeutic agents; Titanocene dichloride

Indexed keywords

ANTINEOPLASTIC AGENT; BUDOTITANE; HORSERADISH PEROXIDASE; TITANOCENE DICHLORIDE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TESTIS BARRIER; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; INCUBATION TIME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMINIFEROUS TUBULE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-TESTIS BARRIER; HORSERADISH PEROXIDASE; MALE; MICE; MICE, INBRED ICR; ORGANOMETALLIC COMPOUNDS; TESTIS; TITANIUM;

EID: 36048929785     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110017     Document Type: Article

References (7)

1. Caruso F, Rossi M: Antitumor titanium compounds. Mini Rev Med Chem 2004;4:49-60.
2. Oberschmidt O, Hanauske A, Pampillon C, Sweeney N, Strohfeldt K, Tacke M: Antiproliferative activity of Titanocene Y against tumor colony-forming units. Anticancer Drugs 2007;18:317-321.
3. Meléndez E: Titanium complexes in cancer treatment. Crit Rev Oncol Hematol 2002;42:309-315.
4. Yang TS, Chen JS, Tang R, Chiang JM, Hsieh PS, Yeh CY, Changchien CR: Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: a phase II study. Chemotherapy 2003;49:194-199.
5. Pereira ML, Santos TM, Garcia e Costa F, Pedrosa de Jesus J: Functional changes of mice Sertoli cells induced by Cr(V). Cell Biol Toxicol 2004;20:285-291.
6. Wong C, Cheng C: The blood-testis barrier: its biology, regulation, and physiological role in spermatogenesis. Curr Top Dev Biol 2005;71:263-296.
7. Pluta R: Pathological opening of the bloodbrain barrier to horseradish peroxidase and amyloid precursor protein following ischemia-reperfusion brain injury. Chemotherapy 2005;51:223-226.